Company attributes
Other attributes
Dr. Haseltine is the CEO of Demetrix and was previously professor and founder of two departments at Harvard Medical School, one on HIV/AIDS and one on cancer biology. Dr. Haseltine led Human Genome Sciences, one of the first companies to apply genetics to treat disease, and founded several other biotechnology companies. Dr. Haseltine leads the Haseltine Foundation for Science and the Arts, and ACCESS Health International, both non-profits in health and the humanities.
Demetrix is named after Demeter, the greek goddess of the harvest.